Skip to main content
PMC home page
The BMJ logoLink to The BMJ
editorial
. 1991 Jun 15;302(6790):1414–1415. doi: 10.1136/bmj.302.6790.1414

The daughters of stilboestrol.

M Wingfield
PMCID: PMC1670127  PMID: 2070103

Full text

PDF
1414

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson B., Watring W. G., Edinger D. D., Jr, Small E. C., Netland A. T., Safaii H. Development of DES-associated clear-cell carcinoma: the importance of regular screening. Obstet Gynecol. 1979 Mar;53(3):293–299. [PubMed] [Google Scholar]
  2. Barnes A. B., Colton T., Gundersen J., Noller K. L., Tilley B. C., Strama T., Townsend D. E., Hatab P., O'Brien P. C. Fertility and outcome of pregnancy in women exposed in utero to diethylstilbestrol. N Engl J Med. 1980 Mar 13;302(11):609–613. doi: 10.1056/NEJM198003133021105. [DOI] [PubMed] [Google Scholar]
  3. Davis J. A., Wadehra V., McIntosh A. S., Monaghan J. M. A case of clear cell adenocarcinoma of the vagina in pregnancy. Br J Obstet Gynaecol. 1981 Mar;88(3):322–326. doi: 10.1111/j.1471-0528.1981.tb00989.x. [DOI] [PubMed] [Google Scholar]
  4. Greenberg E. R., Barnes A. B., Resseguie L., Barrett J. A., Burnside S., Lanza L. L., Neff R. K., Stevens M., Young R. H., Colton T. Breast cancer in mothers given diethylstilbestrol in pregnancy. N Engl J Med. 1984 Nov 29;311(22):1393–1398. doi: 10.1056/NEJM198411293112201. [DOI] [PubMed] [Google Scholar]
  5. Greenwald P., Barlow J. J., Nasca P. C., Burnett W. S. Vaginal cancer after maternal treatment with synthetic estrogens. N Engl J Med. 1971 Aug 12;285(7):390–392. doi: 10.1056/NEJM197108122850707. [DOI] [PubMed] [Google Scholar]
  6. Herbst A. L., Robboy S. J., Scully R. E., Poskanzer D. C. Clear-cell adenocarcinoma of the vagina and cervix in girls: analysis of 170 registry cases. Am J Obstet Gynecol. 1974 Jul 1;119(5):713–724. [PubMed] [Google Scholar]
  7. Herbst A. L., Scully R. E., Robboy S. J. Editorial: Problems in the examination of the DES-exposed female. Obstet Gynecol. 1975 Sep;46(3):353–355. [PubMed] [Google Scholar]
  8. Herbst A. L., Ulfelder H., Poskanzer D. C. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971 Apr 15;284(15):878–881. doi: 10.1056/NEJM197104222841604. [DOI] [PubMed] [Google Scholar]
  9. Jefferies J. A., Robboy S. J., O'Brien P. C., Bergstralh E. J., Labarthe D. R., Barnes A. B., Noller K. L., Hatab P. A., Kaufman R. H., Townsend D. E. Structural anomalies of the cervix and vagina in women enrolled in the Diethylstilbestrol Adenosis (DESAD) Project. Am J Obstet Gynecol. 1984 Jan 1;148(1):59–66. doi: 10.1016/s0002-9378(84)80033-2. [DOI] [PubMed] [Google Scholar]
  10. Kinlen L. J., Badaracco M. A., Moffett J., Vessey M. P. A survey of the use of oestrogens during pregnancy in the United Kingdom and of the genito-urinary cancer mortality and incidence rates in young people in England and Wales. J Obstet Gynaecol Br Commonw. 1974 Nov;81(11):849–855. doi: 10.1111/j.1471-0528.1974.tb00395.x. [DOI] [PubMed] [Google Scholar]
  11. Kramer M. S., Seltzer V., Krumholz B., Talebian F., Tedeschi C., Chen S. Diethylstilbestrol-related clear-cell adenocarcinoma in women with initial examinations demonstrating no malignant disease. Obstet Gynecol. 1987 Jun;69(6):868–871. [PubMed] [Google Scholar]
  12. Ludmir J., Landon M. B., Gabbe S. G., Samuels P., Mennuti M. T. Management of the diethylstilbestrol-exposed pregnant patient: a prospective study. Am J Obstet Gynecol. 1987 Sep;157(3):665–669. doi: 10.1016/s0002-9378(87)80025-x. [DOI] [PubMed] [Google Scholar]
  13. Melnick S., Cole P., Anderson D., Herbst A. Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update. N Engl J Med. 1987 Feb 26;316(9):514–516. doi: 10.1056/NEJM198702263160905. [DOI] [PubMed] [Google Scholar]
  14. Michaels W. H., Thompson H. O., Schreiber F. R., Berman J. M., Ager J., Olson K. Ultrasound surveillance of the cervix during pregnancy in diethylstilbestrol-exposed offspring. Obstet Gynecol. 1989 Feb;73(2):230–239. [PubMed] [Google Scholar]
  15. Monaghan J. M., Sirisena L. A. Stilboestrol and vaginal clear-cell adenocarcinoma syndrome. Br Med J. 1978 Jun 17;1(6127):1588–1590. doi: 10.1136/bmj.1.6127.1588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Robboy S. J., Noller K. L., O'Brien P., Kaufman R. H., Townsend D., Barnes A. B., Gundersen J., Lawrence W. D., Bergstrahl E., McGorray S. Increased incidence of cervical and vaginal dysplasia in 3,980 diethylstilbestrol-exposed young women. Experience of the National Collaborative Diethylstilbestrol Adenosis Project. JAMA. 1984 Dec 7;252(21):2979–2983. [PubMed] [Google Scholar]
  17. Sandberg E. C., Riffle N. L., Higdon J. V., Getman C. E. Pregnancy outcome in women exposed to diethylstilbestrol in utero. Am J Obstet Gynecol. 1981 May 15;140(2):194–205. doi: 10.1016/0002-9378(81)90108-3. [DOI] [PubMed] [Google Scholar]
  18. Schmidt G., Fowler W. C., Jr Cervical stenosis following minor gynecologic procedures on DES-exposed women. Obstet Gynecol. 1980 Sep;56(3):333–335. [PubMed] [Google Scholar]
  19. Senekjian E. K., Potkul R. K., Frey K., Herbst A. L. Infertility among daughters either exposed or not exposed to diethylstilbestrol. Am J Obstet Gynecol. 1988 Mar;158(3 Pt 1):493–498. doi: 10.1016/0002-9378(88)90012-9. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES